Home / 2018 / September

Monthly Archives: September 2018

Regenerative Medicine and the FDA: 4 Areas of Concern

FDA regulators made no bones about it in 2017 when they announced their intention to go after the fledgling regenerative medicine industry. After multiple news reports detailing stem cell procedures gone awry, the federal government’s healthcare regulatory agency decided enough was enough. In the 14 months since, they have been …

Read More »